Promoter Methylation Analysis of May Be a Potential Biomarker for Early Detection of Cervical Cancer

Overview

Journal Asian Biomed (Res Rev News)

Date 2023 Aug 8

PMID 37551167

Authors

Xian Zhang

Aihua Li

Jie Wu

Yu Wu

Xiaoping Ma

Yanjun Liu

Qingfa Chen

Yan Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Dickkopf 2 () plays an important role in multiple cancers. Its potential value in the clinical diagnosis of cervical cancer has remained unclear.

Objectives: To investigate the expression and promoter methylation levels of in cervical cancer and their clinicopathological associations.

Methods: We used the Gene Expression Omnibus, Oncomine, Cancer Genome Atlas, and University of ALabama at Birmingham CANcer data analysis databases, reverse transcription-PCR, and methylation-specific PCR analysis to predict and examine the expression of DKK2 mRNA and methylation levels in cell lines and cervical cancer tissues from 79 patients with cervical cancer and 63 with cervical precancerous lesions including 25 with low-grade squamous intraepithelial lesions (LSIL) and 38 patients with high-grade squamous intraepithelial lesions (HSIL).

Results: DKK2 mRNA expression was downregulated in all cancer cell lines and cervical cancer tissues, whereas hypermethylation of was higher in cervical cancer tissue samples. methylation in cervical cancer was significantly higher than that in HSIL (χ = 8.346, = 0.004), whereas methylation in HSIL was significantly higher than that in normal cervical samples (χ = 7.934, = 0.005) and in LSIL samples (χ = 4.375, = 0.037). silencing caused by its promoter hypermethylation was confirmed by treatment with the methyltransferase inhibitor 5-Aza-dC in cell lines. Patients with lymph node metastasis exhibited increased promoter methylation frequency (χ = 5.239, = 0.022) and low DKK2 mRNA expression (χ = 3.958, = 0.047) compared with patients with no lymph node metastasis. Patients with high-risk human papillomavirus infection exhibited increased promoter methylation frequency (χ = 6.279, = 0.015).

Conclusions: epigenetic changes of DKK2 may play a key role in the development of cervical cancer, suggesting that hypermethylation could be used as a triage test for screening, early diagnosis, or risk prediction of cervical cancer.

Citing Articles

The assessment of Dickkopf-1 and Dickkopf-2 protein concentration in different subtypes of non-small cell lung cancer subtypes.

Hudy D, Gazdzicka J, Swietek A, Golabek K, Rydel M, Czyzewski D Contemp Oncol (Pozn). 2024; 28(1):9-14.

PMID: 38800531 PMC: 11117157. DOI: 10.5114/wo.2024.136981.

References

Uren A, Wolf V, Sun Y, Azari A, Rubin J, Toretsky J . Wnt/Frizzled signaling in Ewing sarcoma. Pediatr Blood Cancer. 2004; 43(3):243-9. DOI: 10.1002/pbc.20124. View

He Y, Su R, Zheng J . Detection of DKK-1 gene methylation in exfoliated cells of cervical squamous cell carcinoma and its relationship with high risk HPV infection. Arch Gynecol Obstet. 2021; 304(3):743-750. DOI: 10.1007/s00404-021-05982-3. View

Schagdarsurengin U, Wilkens L, Steinemann D, Flemming P, Kreipe H, Pfeifer G . Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Oncogene. 2003; 22(12):1866-71. DOI: 10.1038/sj.onc.1206338. View

Shao Y, Nie X, Song G, Wei Y, Xia P, Xu X . Prognostic value of DKK2 from the Dickkopf family in human breast cancer. Int J Oncol. 2018; 53(6):2555-2565. PMC: 6203157. DOI: 10.3892/ijo.2018.4588. View

Sato H, Suzuki H, Toyota M, Nojima M, Maruyama R, Sasaki S . Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. Carcinogenesis. 2007; 28(12):2459-66. DOI: 10.1093/carcin/bgm178. View

Costello J, Fruhwald M, Smiraglia D, Rush L, Robertson G, Gao X . Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet. 2000; 24(2):132-8. DOI: 10.1038/72785. View

Wang C, Yue Y, Shao B, Qiu Z, Mu J, Tang J . Dickkopf-Related Protein 2 is Epigenetically Inactivated and Suppresses Colorectal Cancer Growth and Tumor Metastasis by Antagonizing Wnt/β-Catenin Signaling. Cell Physiol Biochem. 2017; 41(5):1709-1724. DOI: 10.1159/000471861. View

McShane L, Altman D, Sauerbrei W, Taube S, Gion M, Clark G . REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat. 2006; 100(2):229-35. DOI: 10.1007/s10549-006-9242-8. View

Silva T, Vidigal V, Felipe A, de Lima J, Artigiani Neto R, Saad S . DNA methylation as an epigenetic biomarker in colorectal cancer. Oncol Lett. 2013; 6(6):1687-1692. PMC: 3834199. DOI: 10.3892/ol.2013.1606. View

10.

Wang K, Lin C, Liu C, Liu D, Huang R, Ding D . Global methylation silencing of clustered proto-cadherin genes in cervical cancer: serving as diagnostic markers comparable to HPV. Cancer Med. 2014; 4(1):43-55. PMC: 4312117. DOI: 10.1002/cam4.335. View

11.

Chandrashekar D, Bashel B, Balasubramanya S, Creighton C, Ponce-Rodriguez I, Chakravarthi B . UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 2017; 19(8):649-658. PMC: 5516091. DOI: 10.1016/j.neo.2017.05.002. View

12.

Sugai T, Yoshida M, Eizuka M, Uesugii N, Habano W, Otsuka K . Analysis of the DNA methylation level of cancer-related genes in colorectal cancer and the surrounding normal mucosa. Clin Epigenetics. 2017; 9:55. PMC: 5437595. DOI: 10.1186/s13148-017-0352-4. View

13.

Goeppert B, Konermann C, Schmidt C, Bogatyrova O, Geiselhart L, Ernst C . Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway. Hepatology. 2013; 59(2):544-54. DOI: 10.1002/hep.26721. View

14.

Woodman C, Collins S, Young L . The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer. 2006; 7(1):11-22. DOI: 10.1038/nrc2050. View

15.

Wang H, Duan X, Qi X, Meng L, Xu Y, Wu T . Concurrent Hypermethylation of and Activates the Wnt/β-Catenin Pathway and Is Associated with Poor Prognosis in Patients with Gastric Cancer. Mol Cells. 2017; 40(1):45-53. PMC: 5303888. DOI: 10.14348/molcells.2017.2245. View

16.

Murata H, Tsuji S, Tsujii M, Sakaguchi Y, Fu H, Kawano S . Promoter hypermethylation silences cyclooxygenase-2 (Cox-2) and regulates growth of human hepatocellular carcinoma cells. Lab Invest. 2004; 84(8):1050-9. DOI: 10.1038/labinvest.3700118. View

17.

Nikolaidis C, Nena E, Panagopoulou M, Balgkouranidou I, Karaglani M, Chatzaki E . PAX1 methylation as an auxiliary biomarker for cervical cancer screening: a meta-analysis. Cancer Epidemiol. 2015; 39(5):682-6. DOI: 10.1016/j.canep.2015.07.008. View

18.

Zhu J, Zhang S, Gu L, Di W . Epigenetic silencing of DKK2 and Wnt signal pathway components in human ovarian carcinoma. Carcinogenesis. 2012; 33(12):2334-43. DOI: 10.1093/carcin/bgs278. View

19.

Hirata H, Hinoda Y, Nakajima K, Kawamoto K, Kikuno N, Kawakami K . Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways. Clin Cancer Res. 2009; 15(18):5678-87. DOI: 10.1158/1078-0432.CCR-09-0558. View

20.

Greenlee R, Murray T, Bolden S, Wingo P . Cancer statistics, 2000. CA Cancer J Clin. 2000; 50(1):7-33. DOI: 10.3322/canjclin.50.1.7. View